Skip to content

The Approach of Biliary Drainage in Hepatolithiasis Patients With Sphincter of Oddi Laxity

A Clinical Randomized Trial Comparing T-tube Drainage Versus Choledochojejunostomy in Hepatolithiasis Patients With Sphincter of Oddi Laxity

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04218669
Acronym
BD
Enrollment
105
Registered
2020-01-06
Start date
2020-02-01
Completion date
2025-12-30
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sphincter of Oddi Laxity

Keywords

sphincter of Oddi laxity, hepatolithiasis, choledochojejunostomy

Brief summary

Residual and recurrent stones remain one of the most important challenges of hepatolithiasis which is reported in 20% to 50% of patients treated with these therapies. Up to now the most two common surgical procedures performed were choledochojejunostomy and T tube drainage as biliary drainage in hepatolithiasis. The goal of the present study was to evaluate the therapeutic safety, and perioperative and long-term outcomes of choledochojejunostomy versus T tube drainage for hepatolithiasis with sphincter of Oddi laxity.

Detailed description

Background: SOL results in reflux of duodenal fluid and enteric bacteria infection, which lead to the formation of stones in the biliary tract. Roux-en-Y hepaticojejunostomy (HJ) shows considerable advantage for prevention of reflux of intestinal content into the bile duct. As a result, A randomized controlled trial (RCT) evaluate the therapeutic safety, and perioperative and long-term outcomes of HJ versus T tube drainage for hepatolithiasis with SOL. Intervention: In total, 210 patients who met the following eligibly criteria were included and were randomized to choledochojejunostomy arm or T tube drainage in a 1:1 ratio. Clinical data include: the incidence of biliary complications (stone recurrence; biliary stricture; cholangitis); sphincter of oddi function; biliary leakage; mortality; hepatic injury; quality of life.

Interventions

The common hepatic duct was cut and the duodenal side is closed by suture. The small intestine was cut off 15 cm below the ligament of Treitz. The distal end was lifted, and a 1-2 cm incision was made at the jejunal wall 4-5 cm from the jejunal stump. The anastomosis is used a 5-0 PSD Ⅱ suture, with double needles, inside-out in the jejunum and outside-in in the hepatic duct. One side of needles was used to continuely penetrate and suture the whole layer of the posterior-lateral wall of the jejunum, the posterior-lateral wall of the biliary duct, and the other side of needles was used to continuely stuere the anterior part of the anastomosis. Mucosa-to-mucosa contact should be ensured with every stitch.The anastomotic stomas were then checked for leakage. Enteric-enteric anastomosis was performed 60 cm below the site of the hepatojejunal anastomosis.

PROCEDURET-tube drainage

The T-tube was placed for biliary drainage and the common bile duct was intermittently sutured with 4-0 vicryl sutures.

Sponsors

xpgeng
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

Blinding of the surgeons and patients is not feasible due to the obviously different characteristics of the two types of biliary drainage. Investigator and outcome assessors will be blinded to the trial intervention.

Intervention model description

Patients were randomized to choledochojejunostomy arm or T tube drainage arm

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Age age between 18 and 70 years 2. Diagnosed as hepatolithiasis with sphincter of oddi laxity during operation 3. Achieved removing the focus, extraction of stones and correction of stricture during the operation 4. Written Informed consent 5. Willingness for complete 3-year follow-up.

Exclusion criteria

1. Participation in concurrent intervention trials with interference of outcome of this study 2. Associated tumor 3. Diagnosed as sphincter of oddi complete loss of function or normal 4. Underwent choledochojejunostomy at past 5. Lack of compliance

Design outcomes

Primary

MeasureTime frameDescription
stone recurrence rate3 yearsA recurrence stone was defined as a stone detected more than 3 months after surgery by any diagnostic method. (%)
biliary stricturer rate3 yearsBiliary stricture defined as clinically evident stenosis and subclinical stenosis proved by endoscopic examination or reoperation (%)
Cholangitis rate3 yearsThe diagnosis of cholangitis is based on clinically evident (abdominal discomfort/pain, jaundice or fever associated with hepatolithiasis (%)

Secondary

MeasureTime frameDescription
total bilirubin90 daysserum total bilirubin on 3 postoperative day (umol/L)
sphincter of oddi functionan expected average of 120 minutesGrading criteria for the SO function were as follows: Normal; Laxity and Loss of function
quality of life grading3 yearsQuality of life will be assessed by Visick score (Ⅰ~Ⅳ).
Mortality90 daysOperative mortality was defined as any death resulting from a complication during surgery
Biliary leakage90 daysBiliary leakage was documented in line with the International Study Group of Liver Surgery (ISGLS) definitions and grading systems

Contacts

Primary ContactBao F Liu, doctor
liufubao88@163.com+8613515662646
Backup ContactMing J Chen, doctor
chenjm10@126.com+8615855518651

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026